ABIDJAN, Côte d’Ivoire. December 8, 2017—A global network of activists is calling on pharmaceutical company ViiV Healthcare to allow people living with the human immunodeficiency virus (HIV) in Algeria to get more affordable access to treatment in that country. Activists representing several advocacy groups recently staged a high-profile protest demanding that ViiV Healthcare give people […]
The ambition to achieve treatment optimization for people living with HIV could finally be realized – but this World AIDS Day (1 December 2017), activists warn of the creation of a treatment quality gap, where millions may be left behind. In 2018, treatment optimization may become a reality for many people living with HIV, with […]
On 22-26 July 2017, ITPC Global, Regional Directors from ITPC LATCA and ITPC MENA, and representatives from ITPCru were in Paris, France for the 2017 International AIDS Society Conference on HIV Science (IAS 2017). With support from the Bridging the Gaps initiative, we were able to ensure treatment access issues – particularly as they affect key populations […]
FOR IMMEDIATE RELEASE SEPTEMBER 19, 2014 A Step Back for Millions of People with Hepatitis C: Why Gilead’s Recent Deal with Generic Producers for its Hepatitis C Drugs (Sofosbuvir and Ledipasvir) is a Sham Hepatitis C Virus (HCV) Treatment: Gilead Sciences Voluntary License Under the pretext of increasing access to its hepatitis C treatment, the […]
Following an intensive period of internal reflection and external review, ITPC is proud to present our new strategic plan. The new plan will guide our work over the next three years and outlines….
On 9-13 March 2015, ITPC, in collaboration with the Aids and Rights Alliance for Southern Africa (ARASA), facilitated an HIV and TB financing activist workshop aimed at strengthening key population advocacy for the best use of Global Fund resources and sustainable funding for HIV & TB in Botswana, Malawi and Tanzania. The meeting brought together […]
And this is exactly what ITPC has been advocating for at global level for so many years: for treatment programmes to work in the long run, you need to support community-initiated and -run treatment education projects…
The project, which is supported by UNITAID, will take place over the next three years and aims to remove patent barriers to generic competition in Argentina, Brazil, Ukraine and Thailand by reforming patent laws, challenging undeserved patents and advocating for the selective use of compulsory licenses. The three-day meeting was held at the Merlin Hotel […]